HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F A Shepherd Selected Research

F A Shepherd Research Topics

Disease

25Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2020 - 02/2000
11Neoplasms (Cancer)
01/2017 - 02/2000
5Lung Neoplasms (Lung Cancer)
12/2020 - 08/2000
5Adenocarcinoma
10/2010 - 02/2000
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2010 - 04/2001
3Diarrhea
11/2020 - 05/2000
3Exanthema (Rash)
11/2020 - 07/2008
3Hypertension (High Blood Pressure)
03/2014 - 11/2010
2Brain Neoplasms (Brain Tumor)
12/2018 - 05/2000
2Neoplasm Metastasis (Metastasis)
01/2018 - 02/2000
2Infections
10/2013 - 02/2008
2Anemia
06/2007 - 03/2007
1Nausea
11/2020
1Disease Progression
01/2020
1Epilepsy (Aura)
01/2018
1Anorexia
03/2014
1Venous Thrombosis (Deep-Vein Thrombosis)
08/2012
1Pulmonary Embolism
08/2012
1Leukemia
01/2012
1Vomiting
10/2010
1Carcinogenesis
05/2006
1Carcinoma (Carcinomatosis)
08/2001
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2001
1Adenocarcinoma of Lung
08/2000
1Febrile Neutropenia
05/2000
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2000

Drug/Important Bio-Agent (IBA)

5Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2019 - 07/2008
4Cisplatin (Platino)FDA LinkGeneric
03/2007 - 11/2000
3Tyrosine Kinase InhibitorsIBA
12/2020 - 01/2009
3PlatinumIBA
11/2020 - 05/2000
3ErbB Receptors (EGF Receptor)IBA
11/2020 - 08/2000
3Proteins (Proteins, Gene)FDA Link
01/2017 - 02/2000
3Biomarkers (Surrogate Marker)IBA
07/2015 - 11/2010
3Paclitaxel (Taxol)FDA LinkGeneric
03/2014 - 05/2000
3Docetaxel (Taxotere)FDA Link
08/2011 - 05/2000
3Metalloproteases (Metalloproteinases)IBA
02/2008 - 02/2000
2Pemetrexed (MTA)FDA Link
11/2020 - 08/2001
2osimertinibIBA
11/2020 - 01/2018
2Gefitinib (Iressa)FDA Link
01/2019 - 08/2011
2Carboplatin (JM8)FDA LinkGeneric
03/2014 - 11/2010
2cediranib (AZD2171)IBA
03/2014 - 11/2010
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2014 - 11/2010
2Angiogenesis InhibitorsIBA
11/2010 - 12/2001
2Matrix Metalloproteinases (MMPs)IBA
02/2008 - 02/2000
1naquotinibIBA
01/2019
1NivolumabIBA
12/2018
1Immune Checkpoint InhibitorsIBA
01/2017
1B7-H1 AntigenIBA
01/2017
1LigandsIBA
01/2017
1L-BLP25IBA
06/2015
1figitumumabIBA
03/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012
1TubulinIBA
01/2012
1CarcinogensIBA
07/2011
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2007
1Vinorelbine (Navelbine)FDA LinkGeneric
03/2007
1Hemoglobins (Hemoglobin)IBA
03/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2006
1liposomal doxorubicin (Doxil)FDA Link
06/2006
1Vincristine (Oncovin)FDA LinkGeneric
06/2006
1Telomerase (Telomerase Reverse Transcriptase)IBA
05/2006
1Messenger RNA (mRNA)IBA
05/2006
1InterferonsIBA
12/2001
1Folic Acid AntagonistsIBA
08/2001
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
03/2001
1GemcitabineFDA Link
11/2000
1Phosphotransferases (Kinase)IBA
08/2000
1Transforming Growth Factor alpha (TGF-alpha)IBA
08/2000
1Tissue Inhibitor of Metalloproteinase-2IBA
02/2000
1Tissue Inhibitor of Metalloproteinase-1IBA
02/2000

Therapy/Procedure

12Drug Therapy (Chemotherapy)
01/2020 - 05/2000
10Therapeutics
01/2020 - 03/2001
4Adjuvant Chemotherapy
01/2017 - 03/2007
2Time-to-Treatment
12/2018 - 07/2015
2Radiotherapy
06/2006 - 04/2001
1Palliative Care (Palliative Therapy)
01/2020
1Chemoradiotherapy
06/2015
1Immunotherapy
06/2015
1Drug Tapering
10/2010
1Regimen B
03/2001
1Liver Transplantation
03/2001